The estimated Net Worth of Easterly Partners Llcle Par... is at least $43.8 Milione dollars as of 17 September 2019. Easterly Par owns over 577,197 units of Standard BioTools Inc stock worth over $25,635,621 and over the last 6 years Easterly sold FLDM stock worth over $18,205,830.
Easterly has made over 18 trades of the Standard BioTools Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Easterly sold 577,197 units of FLDM stock worth $3,116,864 on 17 September 2019.
The largest trade Easterly's ever made was selling 577,197 units of Standard BioTools Inc stock on 17 September 2019 worth over $3,116,864. On average, Easterly trades about 147,370 units every 8 days since 2019. As of 17 September 2019 Easterly still owns at least 6,909,871 units of Standard BioTools Inc stock.
You can see the complete history of Easterly Par stock trades at the bottom of the page.
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... e Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Standard BioTools Inc executives and other stock owners filed with the SEC include: